Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?

Page 2 of 2

Using the results demonstrated by the previously mentioned tactics, average investors should always keep one eye on hedge fund and insider trading activity, and Pain Therapeutics, Inc. (NASDAQ:PTIE) applies perfectly to this mantra.

Discover how hedge fund piggybacking can benefit you

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Cytokinetics, Inc. (NASDAQ:CYTK) 8 0 0
ArQule, Inc. (NASDAQ:ARQL) 10 0 0
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 7 0 0
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) 8 0 0
Amicus Therapeutics, Inc. (NASDAQ:FOLD) 13 0 0
Page 2 of 2